Sign In
Buy AMRX
$12.88
+0.225 (+1.78%)
At Close: Jun 03, 2026
Does Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Have A Particularly Volatile Share Price?
10:18am, Tuesday, 12'th May 2020
If you're interested in Amneal Pharmaceuticals, Inc. (NYSE:AMRX), then you might want to consider its beta (a measure...
U.S. RESEARCH ROUNDUP-Digital Realty Trust, Pilgrims Pride, Terraform Power
07:26am, Tuesday, 12'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power,
on Tuesday.
HIGH
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2020 Earnings Call Transcript
12:00am, Tuesday, 12'th May 2020
Image source: The Motley Fool. Amneal Pharmaceuticals, Inc. (NYSE: AMRX)Q1 2020 Earnings CallMay 11, 2020, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared
6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
12:00am, Tuesday, 12'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Amyris Inc, BioCryst Pharmaceuticals Inc, Cytokinetics Inc. Read Harry Boxer's latest article on Investing.com
Amneal Pharmaceuticals Inc. (AMRX) CEO Chirag Patel on Q1 2020 Results - Earnings Call Transcript
07:15pm, Monday, 11'th May 2020
Amneal Pharmaceuticals Inc. (NYSE:AMRX) Q1 2020 Earnings Conference Call May 11, 2020 08:30 AM ET Company Participants Tasos Konidaris - SVP and CFO Chirag Pate
Amneal Pharmaceuticals (AMRX) Surpasses Q1 Earnings and Revenue Estimates
03:35pm, Monday, 11'th May 2020
Amneal (AMRX) delivered earnings and revenue surprises of 150.00% and 12.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Amneal Pharmaceuticals: Q1 Earnings Insights
12:43pm, Monday, 11'th May 2020
Shares of Amneal Pharmaceuticals (NYSE:AMRX) moved higher by 13% in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share rose 42.86% year over year to $0.20, w
Amneal Reports First Quarter 2020 Financial Results
10:30am, Monday, 11'th May 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the "Company") announced its results today for the first quarter ended March 31, 2020.
Amneal Reports First Quarter 2020 Financial Results
12:00am, Monday, 11'th May 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the first quarter ended March 31, 2020. “We are proud of how
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Is a Surprise Coming for Amneal (AMRX) This Earnings Season?
12:53pm, Friday, 08'th May 2020
Amneal (AMRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The epinephrine autoinjector market is poised to grow by 762.51 mn during 2020-2024, according to Technavio
Was The Smart Money Right About Amneal Pharmaceuticals, Inc. (AMRX)?
10:49pm, Wednesday, 06'th May 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Patent Filings Roundup: Blackberry Accused of Abuse, PayPal Isn’t Playing, WSOU Earns Its Frequent Filer Card
11:15am, Wednesday, 06'th May 2020
This week in patent filings, PTAB filings are back up, with four post grant reviews and 37 inter partes reviews, while there were 83 district court complaints; the district court numbers skew high bec
